Dr. Paul Savoca

Lawrence Stern is a Colorectal Surgeon in Fairfax, Virginia. Dr. Stern is rated as a Distinguished provider by MediFind in the treatment of Cronkhite-Canada Disease. His top areas of expertise are Familial Colorectal Cancer, Proctitis, Mesenteric Venous Thrombosis, Colostomy, and Ileostomy.

Dr. John Migaly is a distinguished colorectal surgeon and Chief of the Division of Colorectal Surgery/Ravitch Division at Johns Hopkins Medicine. He specializes in the treatment of colorectal cancer, inflammatory bowel disease, and other benign and complex colorectal conditions. Dr. Migaly is committed to providing advanced, patient-centered care, often using minimally invasive techniques including laparoscopic and robotic surgery, to help reduce recovery time and improve outcomes. Dr. Migaly comes to Johns Hopkins Medicine from the Duke University School of Medicine, serving from 2008-2024 on the surgery faculty treating patients primarily through the Duke Cancer Institute. He was elevated to Program Director of the General Surgery Residency in 2012, and subsequently served as Vice Chair of Education until 2024. His work was critical to the success of the undergraduate, graduate, and continuing medical education missions at Duke Surgery. Dr. Migaly earned his B.A. in Biochemistry from New York University and his medical degree from the New York University School of Medicine. He completed surgical residency and a research fellowship at Temple University Health Sciences Center, and colorectal surgery fellowship at Cleveland Clinic Florida. Dr. Migaly’s career has been marked not only by a complex and high-volume clinical colon and rectal surgery practice, but also a commitment to research and education, supported by greater than 200 publications, book chapters, and presentations. His research is centered around improving practice patterns and outcomes in colorectal cancer care and recovery. His leadership and dedication to advancing the field of colorectal surgery is evident through his service on committees that shape how colorectal care is delivered nationally, via his past and present service on the Program Committee, the Clinical Practice Guidelines Committee and the Diversity and Inclusion Committee of the American Society of Colon and Rectal Surgeons. Videos John Migaly, M.D.Chief of Colorectal Surgery"". Dr. Migaly is rated as a Distinguished provider by MediFind in the treatment of Cronkhite-Canada Disease. His top areas of expertise are Familial Colorectal Cancer, Gastroesophageal Junction Cancer, Anal Cancer, Colostomy, and Ileostomy.

"A colorectal surgeon, Dr. Bafford specializes in the treatment of colorectal cancer, inflammatory bowel disease, and benign diseases of the colon, rectum and anus. ""These diseases are very treatable. The surgeries I perform are effective at curing cancer or treating colitis, which allows my patients back to the quality of life they want to have. It's very rewarding to see that type of recovery with so many of my patients,"" she says. Dr. Bafford's special interests include laparoscopic and robotic minimally invasive surgery, approaches that are associated with less pain and a faster recovery. Treatments she offers include surgical treatment of inflammatory bowel disease, sphincter-sparing surgery and organ preservation for rectal cancer, surgery for anorectal disorders, minimally invasive surgery for diverticulitis, treatment of rectal prolapse, and screening and therapeutic colonoscopy. Dr. Bafford has authored or co-authored numerous publications in leading peer-reviewed scientific journals and textbooks. Her research interests are in the pathophysiology of colorectal cancer, disparities in colorectal surgery and the surgical management of inflammatory bowel disease. Her passion and dedication have earned her a consistent spot on Baltimore magazine's ""Top Doctor"" lists for colon and rectal surgery. Videos Andrea Chao Bafford M.D.Colorectal Surgeon Research Summary Dr. Bafford's research has largely focused on IBD. Utilizing institutional databases and the NSQIP IBD, she has investigated perioperative outcomes in IBD patients as they relate to sex, immunosuppressive medical therapy, trauma, preoperative drainage of abscesses, and fecal diversion. She has also published on the microbiota of perianal Crohn’s disease with the help of an intramural grant. In addition, through interdepartmental collaboration, Dr. Bafford has contributed towards intestinal organoid preparation and 3D colon cancer organoid development used to study immune responses to intestinal infections, intestinal immunity, and colon cancer pathogenesis.". Dr. Bafford is rated as a Distinguished provider by MediFind in the treatment of Cronkhite-Canada Disease. Her top areas of expertise are Crohn's Disease, Ulcerative Colitis, Familial Colorectal Cancer, Hernia Surgery, and Ileostomy.